HIF1A and breast carcinoma: HIF-1α is a well-appreciated target for cancer therapies, and drugs that indirectly inhibit hypoxia/HIF-1α signalling such as digoxin and acriflavine, have been reported to have relevant impacts – for example decreasing lung metastasis in an orthotopic breast cancer model [114].